These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 1331327)
1. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites. Nijssen PC; Sexton T; Childers SR J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327 [TBL] [Abstract][Full Text] [Related]
2. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase. Childers SR J Neurochem; 1988 Feb; 50(2):543-53. PubMed ID: 2826699 [TBL] [Abstract][Full Text] [Related]
3. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Childers SR; Fleming L; Konkoy C; Marckel D; Pacheco M; Sexton T; Ward S Ann N Y Acad Sci; 1992 Jun; 654():33-51. PubMed ID: 1321574 [TBL] [Abstract][Full Text] [Related]
4. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Selley DE; Breivogel CS; Childers SR Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223 [TBL] [Abstract][Full Text] [Related]
5. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. Izenwasser S; Búzás B; Cox BM J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389 [TBL] [Abstract][Full Text] [Related]
7. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors. Puttfarcken PS; Werling LL; Cox BM Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651 [TBL] [Abstract][Full Text] [Related]
9. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
10. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
11. Activation of opioid and muscarinic receptors stimulates basal adenylyl cyclase but inhibits Ca2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb. Olianas MC; Onali P J Neurochem; 1994 Jul; 63(1):161-8. PubMed ID: 8207425 [TBL] [Abstract][Full Text] [Related]
12. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma. Niroomand F; Mura RA; Piacentini L; Kübler W Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664 [TBL] [Abstract][Full Text] [Related]
13. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site. Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319 [TBL] [Abstract][Full Text] [Related]
14. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb. Olianas MC; Onali P Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951 [TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotide regulation of [125I]beta-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements. Selley DE; Bidlack JM Brain Res; 1989 Jul; 493(1):23-32. PubMed ID: 2550106 [TBL] [Abstract][Full Text] [Related]
16. Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord. Reddy PL; Bhargava HN Peptides; 1996; 17(4):625-8. PubMed ID: 8804072 [TBL] [Abstract][Full Text] [Related]
17. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites. Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509 [TBL] [Abstract][Full Text] [Related]
18. Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase. Law PY; Wu J; Koehler JE; Loh HH J Neurochem; 1981 May; 36(5):1834-46. PubMed ID: 7241139 [TBL] [Abstract][Full Text] [Related]
19. Relationship between opioid-receptor occupancy and stimulation of low-Km GTPase in brain membranes. Clark MJ; Nordby GL; Medzihradsky F J Neurochem; 1989 Apr; 52(4):1162-9. PubMed ID: 2538562 [TBL] [Abstract][Full Text] [Related]
20. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes. Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]